- 1) The shares of one of my largest short positions (~3%), Exact Sciences, crashed by more than 46% yesterday. Below is the article I published this morning on SeekingAlpha, explaining why I think it’s still a great short and thus shorted more yesterday. Here’s a summary:
- The U.S. Preventative Services Task Force’s Colorectal Cancer Screening Draft Recommendation issued yesterday is devastating for Exact Sciences’ only product, Cologuard.
- I think this is the beginning of the end for the company.
- My price target for the stock a year from now is $3, so I shorted more yesterday.
Also, attached are the slides I presented on it at the Robin Hood Investors Conference a year ago (also posted at: www.tilsonfunds.com/EXAS.pdf).
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
